Human height genes and cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1836, Issue 1, 2013, Pages 27-41

  Tripaldi, Romina ^a   Stuppia, Liborio ^a   Alberti, Saverio ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Cancer; Gene association studies; Height; Heredity; Signaling pathways

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; CYCLIN DEPENDENT KINASE 6; DNA METHYLTRANSFERASE 3A; DYNAMIN; FIBULIN 5; FOCAL ADHESION KINASE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH DIFFERENTIATION FACTOR 5; GROWTH FACTOR RECEPTOR BOUND PROTEIN 10; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; HIGH MOBILITY GROUP A2 PROTEIN; HISTONE; HISTONE H3 METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE; NETRIN 1; NOGGIN; POLYCOMB GROUP PROTEIN; PROTEIN; PROTEIN KINASE LYN; PROTEIN PATCHED 1; SEMAPHORIN; SF3B4; SMALL NUCLEAR RIBONUCLEOPROTEIN; SONIC HEDGEHOG PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 2; TELOMERASE CB PROTEIN 1; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

BODY HEIGHT; BODY SIZE; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; GENE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN HEIGHT GENE; NEOPLASM; NONHUMAN; ORGANOGENESIS; PHYSICAL DEVELOPMENT; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSGENIC ANIMAL;

BODY HEIGHT; HUMANS; NEOPLASM PROTEINS; NEOPLASMS;

EID: 84875234958     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2013.02.002     Document Type: Review

References (196)

1. De Vita V.T., Lawrence T.S., Rosenberg S.A. De Vita, Hellman & Rosenberg's Cancer: Principles & Practice of Oncology, 8th Edition 2008, Lippincott Williams & Wilkins, Philadelphia. 8th ed.
2. Davey Smith G., Hart C., Upton M., Hole D., Gillis C., Watt G., Hawthorne V. Height and risk of death among men and women: aetiological implications of associations with cardiorespiratory disease and cancer mortality. J. Epidemiol. Community Health 2000, 54:97-103.
3. Fraumeni J.F. Stature and malignant tumors of bone in childhood and adolescence. Cancer 1967, 20:967-973.
4. Rao E., Weiss B., Fukami M., Rump A., Niesler B., Mertz A., Muroya K., Binder G., Kirsch S., Winkelmann M., Nordsiek G., Heinrich U., Breuning M.H., Ranke M.B., Rosenthal A., Ogata T., Rappold G.A. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat. Genet. 1997, 16:54-63.
5. Stuppia L., Calabrese G., Gatta V., Pintor S., Morizio E., Fantasia D., Guanciali Franchi P., Rinaldi M.M., Scarano G., Concolino D., Giannotti A., Petreschi F., Anzellotti M.T., Pomilio M., Chiarelli F., Tumini S., Palka G. SHOX mutations detected by FISH and direct sequencing in patients with short stature. J. Med. Genet. 2003, 40:E11.
6. Swerdlow A.J., Schoemaker M.J., Higgins C.D., Wright A.F., Jacobs P.A. Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J. Natl. Cancer Inst. 2005, 97:1204-1210.
7. Swerdlow A.J., Schoemaker M.J., Higgins C.D., Wright A.F., Jacobs P.A. Mortality and cancer incidence in women with extra X chromosomes: a cohort study in Britain. Hum. Genet. 2005, 118:255-260.
8. Filmus J., Capurro M. The role of glypican-3 in the regulation of body size and cancer. Cell Cycle 2008, 7:2787-2790.
9. Green J., Cairns B.J., Casabonne D., Wright F.L., Reeves G., Beral V. Height and cancer incidence in the million women study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol. 2011, 12:785-794.
10. Lettre G., Jackson A.U., Gieger C., Schumacher F.R., Berndt S.I., Sanna S., Eyheramendy S., Voight B.F., Butler J.L., Guiducci C., Illig T., Hackett R., Heid I.M., Jacobs K.B., Lyssenko V., Uda M., Boehnke M., Chanock S.J., Groop L.C., Hu F.B., Isomaa B., Kraft P., Peltonen L., Salomaa V., Schlessinger D., Hunter D.J., Hayes R.B., Abecasis G.R., Wichmann H.E., Mohlke K.L., Hirschhorn J.N. Identification of ten loci associated with height highlights new biological pathways in human growth. Nat. Genet. 2008, 40:584-591.
11. Gudbjartsson D.F., Walters G.B., Thorleifsson G., Stefansson H., Halldorsson B.V., Zusmanovich P., Sulem P., Thorlacius S., Gylfason A., Steinberg S., Helgadottir A., Ingason A., Steinthorsdottir V., Olafsdottir E.J., Olafsdottir G.H., Jonsson T., Borch-Johnsen K., Hansen T., Andersen G., Jorgensen T., Pedersen O., Aben K.K., Witjes J.A., Swinkels D.W., den Heijer M., Franke B., Verbeek A.L., Becker D.M., Yanek L.R., Becker L.C., Tryggvadottir L., Rafnar T., Gulcher J., Kiemeney L.A., Kong A., Thorsteinsdottir U., Stefansson K. Many sequence variants affecting diversity of adult human height. Nat. Genet. 2008, 40:609-615.
12. Weedon M.N., Lango H., Lindgren C.M., Wallace C., Evans D.M., Mangino M., Freathy R.M., Perry J.R., Stevens S., Hall A.S., Samani N.J., Shields B., Prokopenko I., Farrall M., Dominiczak A., Johnson T., Bergmann S., Beckmann J.S., Vollenweider P., Waterworth D.M., Mooser V., Palmer C.N., Morris A.D., Ouwehand W.H., Zhao J.H., Li S., Loos R.J., Barroso I., Deloukas P., Sandhu M.S., Wheeler E., Soranzo N., Inouye M., Wareham N.J., Caulfield M., Munroe P.B., Hattersley A.T., McCarthy M.I., Frayling T.M. Genome-wide association analysis identifies 20 loci that influence adult height. Nat. Genet. 2008, 40:575-583.
13. Cho Y.S., Go M.J., Kim Y.J., Heo J.Y., Oh J.H., Ban H.J., Yoon D., Lee M.H., Kim D.J., Park M., Cha S.H., Kim J.W., Han B.G., Min H., Ahn Y., Park M.S., Han H.R., Jang H.Y., Cho E.Y., Lee J.E., Cho N.H., Shin C., Park T., Park J.W., Lee J.K., Cardon L., Clarke G., McCarthy M.I., Lee J.Y., Oh B., Kim H.L. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat. Genet. 2009, 41:527-534.
14. Lango Allen H., Estrada K., Lettre G., Berndt S.I., Weedon M.N., Rivadeneira F., Willer C.J., Jackson A.U., Vedantam S., Raychaudhuri S., Ferreira T., Wood A.R., Weyant R.J., Segre A.V., Speliotes E.K., Wheeler E., Soranzo N., Park J.H., Yang J., Gudbjartsson D., Heard-Costa N.L., Randall J.C., Qi L., Vernon Smith A., Magi R., Pastinen T., Liang L., Heid I.M., Luan J., Thorleifsson G., Winkler T.W., Goddard M.E., Sin Lo K., Palmer C., Workalemahu T., Aulchenko Y.S., Johansson A., Zillikens M.C., Feitosa M.F., Esko T., Johnson T., Ketkar S., Kraft P., Mangino M., Prokopenko I., Absher D., Albrecht E., Ernst F., Glazer N.L., Hayward C., Hottenga J.J., Jacobs K.B., Knowles J.W., Kutalik Z., Monda K.L., Polasek O., Preuss M., Rayner N.W., Robertson N.R., Steinthorsdottir V., Tyrer J.P., Voight B.F., Wiklund F., Xu J., Zhao J.H., Nyholt D.R., Pellikka N., Perola M., Perry J.R., Surakka I., Tammesoo M.L., Altmaier E.L., Amin N., Aspelund T., Bhangale T., Boucher G., Chasman D.I., Chen C., Coin L., Cooper M.N., Dixon A.L., Gibson Q., Grundberg E., Hao K., Juhani Junttila M., Kaplan L.M., Kettunen J., Konig I.R., Kwan T., Lawrence R.W., Levinson D.F., Lorentzon M., McKnight B., Morris A.P., Muller M., Suh Ngwa J., Purcell S., Rafelt S., Salem R.M., Salvi E., Sanna S., Shi J., Sovio U., Thompson J.R., Turchin M.C., Vandenput L., Verlaan D.J., Vitart V., White C.C., Ziegler A., Almgren P., Balmforth A.J., Campbell H., Citterio L., De Grandi A., Dominiczak A., Duan J., Elliott P., Elosua R., Eriksson J.G., Freimer N.B., Geus E.J., Glorioso N., Haiqing S., Hartikainen A.L., Havulinna A.S., Hicks A.A., Hui J., Igl W., Illig T., Jula A., Kajantie E., Kilpelainen T.O., Koiranen M., Kolcic I., Koskinen S., Kovacs P., Laitinen J., Liu J., Lokki M.L., Marusic A., Maschio A., Meitinger T., Mulas A., Pare G., Parker A.N., Peden J.F., Petersmann A., Pichler I., Pietilainen K.H., Pouta A., Ridderstrale M., Rotter J.I., Sambrook J.G., Sanders A.R., Schmidt C.O., Sinisalo J., Smit J.H., Stringham H.M., Bragi Walters G., Widen E., Wild S.H., Willemsen G., Zagato L., Zgaga L., Zitting P., Alavere H., Farrall M., McArdle W.L., Nelis M., Peters M.J., Ripatti S., van Meurs J.B., Aben K.K., Ardlie K.G., Beckmann J.S., Beilby J.P., Bergman R.N., Bergmann S., Collins F.S., Cusi D., den Heijer M., Eiriksdottir G., Gejman P.V., Hall A.S., Hamsten A., Huikuri H.V., Iribarren C., Kahonen M., Kaprio J., Kathiresan S., Kiemeney L., Kocher T., Launer L.J., Lehtimaki T., Melander O., Mosley T.H., Musk A.W., Nieminen M.S., O'Donnell C.J., Ohlsson C., Oostra B., Palmer L.J., Raitakari O., Ridker P.M., Rioux J.D., Rissanen A., Rivolta C., Schunkert H., Shuldiner A.R., Siscovick D.S., Stumvoll M., Tonjes A., Tuomilehto J., van Ommen G.J., Viikari J., Heath A.C., Martin N.G., Montgomery G.W., Province M.A., Kayser M., Arnold A.M., Atwood L.D., Boerwinkle E., Chanock S.J., Deloukas P., Gieger C., Gronberg H., Hall P., Hattersley A.T., Hengstenberg C., Hoffman W., Lathrop G.M., Salomaa V., Schreiber S., Uda M., Waterworth D., Wright A.F., Assimes T.L., Barroso I., Hofman A., Mohlke K.L., Boomsma D.I., Caulfield M.J., Cupples L.A., Erdmann J., Fox C.S., Gudnason V., Gyllensten U., Harris T.B., Hayes R.B., Jarvelin M.R., Mooser V., Munroe P.B., Ouwehand W.H., Penninx B.W., Pramstaller P.P., Quertermous T., Rudan I., Samani N.J., Spector T.D., Volzke H., Watkins H., Wilson J.F., Groop L.C., Haritunians T., Hu F.B., Kaplan R.C., Metspalu A., North K.E., Schlessinger D., Wareham N.J., Hunter D.J., O'Connell J.R., Strachan D.P., Wichmann H.E., Borecki I.B., van Duijn C.M., Schadt E.E., Thorsteinsdottir U., Peltonen L., Uitterlinden A.G., Visscher P.M., Chatterjee N., Loos R.J., Boehnke M., McCarthy M.I., Ingelsson E., Lindgren C.M., Abecasis G.R., Stefansson K., Frayling T.M., Hirschhorn J.N. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010, 467:832-838.
15. Lanktree M.B., Guo Y., Murtaza M., Glessner J.T., Bailey S.D., Onland-Moret N.C., Lettre G., Ongen H., Rajagopalan R., Johnson T., Shen H., Nelson C.P., Klopp N., Baumert J., Padmanabhan S., Pankratz N., Pankow J.S., Shah S., Taylor K., Barnard J., Peters B.J., Maloney C.M., Lobmeyer M.T., Stanton A., Zafarmand M.H., Romaine S.P., Mehta A., van Iperen E.P., Gong Y., Price T.S., Smith E.N., Kim C.E., Li Y.R., Asselbergs F.W., Atwood L.D., Bailey K.M., Bhatt D., Bauer F., Behr E.R., Bhangale T., Boer J.M., Boehm B.O., Bradfield J.P., Brown M., Braund P.S., Burton P.R., Carty C., Chandrupatla H.R., Chen W., Connell J., Dalgeorgou C., Boer A., Drenos F., Elbers C.C., Fang J.C., Fox C.S., Frackelton E.C., Fuchs B., Furlong C.E., Gibson Q., Gieger C., Goel A., Grobbee D.E., Hastie C., Howard P.J., Huang G.H., Johnson W.C., Li Q., Kleber M.E., Klein B.E., Klein R., Kooperberg C., Ky B., Lacroix A., Lanken P., Lathrop M., Li M., Marshall V., Melander O., Mentch F.D., Meyer N.J., Monda K.L., Montpetit A., Murugesan G., Nakayama K., Nondahl D., Onipinla A., Rafelt S., Newhouse S.J., Otieno F.G., Patel S.R., Putt M.E., Rodriguez S., Safa R.N., Sawyer D.B., Schreiner P.J., Simpson C., Sivapalaratnam S., Srinivasan S.R., Suver C., Swergold G., Sweitzer N.K., Thomas K.A., Thorand B., Timpson N.J., Tischfield S., Tobin M., Tomaszweski M., Verschuren W.M., Wallace C., Winkelmann B., Zhang H., Zheng D., Zhang L., Zmuda J.M., Clarke R., Balmforth A.J., Danesh J., Day I.N., Schork N.J., de Bakker P.I., Delles C., Duggan D., Hingorani A.D., Hirschhorn J.N., Hofker M.H., Humphries S.E., Kivimaki M., Lawlor D.A., Kottke-Marchant K., Mega J.L., Mitchell B.D., Morrow D.A., Palmen J., Redline S., Shields D.C., Shuldiner A.R., Sleiman P.M., Smith G.D., Farrall M., Jamshidi Y., Christiani D.C., Casas J.P., Hall A.S., Doevendans P.A., Christie J.D., Berenson G.S., Murray S.S., Illig T., Dorn G.W., Cappola T.P., Boerwinkle E., Sever P., Rader D.J., Reilly M.P., Caulfield M., Talmud P.J., Topol E., Engert J.C., Wang K., Dominiczak A., Hamsten A., Curtis S.P., Silverstein R.L., Lange L.A., Sabatine M.S., Trip M., Saleheen D., Peden J.F., Cruickshanks K.J., Marz W., O'Connell J.R., Klungel O.H., Wijmenga C., Maitland-van der Zee A.H., Schadt E.E., Johnson J.A., Jarvik G.P., Papanicolaou G.J., Grant S.F., Munroe P.B., North K.E., Samani N.J., Koenig W., Gaunt T.R., Anand S.S., van der Schouw Y.T., Soranzo N., Fitzgerald G.A., Reiner A., Hegele R.A., Hakonarson H., Keating B.J. Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height. Am. J. Hum. Genet. 2011, 88:6-18.
16. Willer C.J., Speliotes E.K., Loos R.J., Li S., Lindgren C.M., Heid I.M., Berndt S.I., Elliott A.L., Jackson A.U., Lamina C., Lettre G., Lim N., Lyon H.N., McCarroll S.A., Papadakis K., Qi L., Randall J.C., Roccasecca R.M., Sanna S., Scheet P., Weedon M.N., Wheeler E., Zhao J.H., Jacobs L.C., Prokopenko I., Soranzo N., Tanaka T., Timpson N.J., Almgren P., Bennett A., Bergman R.N., Bingham S.A., Bonnycastle L.L., Brown M., Burtt N.P., Chines P., Coin L., Collins F.S., Connell J.M., Cooper C., Smith G.D., Dennison E.M., Deodhar P., Elliott P., Erdos M.R., Estrada K., Evans D.M., Gianniny L., Gieger C., Gillson C.J., Guiducci C., Hackett R., Hadley D., Hall A.S., Havulinna A.S., Hebebrand J., Hofman A., Isomaa B., Jacobs K.B., Johnson T., Jousilahti P., Jovanovic Z., Khaw K.T., Kraft P., Kuokkanen M., Kuusisto J., Laitinen J., Lakatta E.G., Luan J., Luben R.N., Mangino M., McArdle W.L., Meitinger T., Mulas A., Munroe P.B., Narisu N., Ness A.R., Northstone K., O'Rahilly S., Purmann C., Rees M.G., Ridderstrale M., Ring S.M., Rivadeneira F., Ruokonen A., Sandhu M.S., Saramies J., Scott L.J., Scuteri A., Silander K., Sims M.A., Song K., Stephens J., Stevens S., Stringham H.M., Tung Y.C., Valle T.T., Van Duijn C.M., Vimaleswaran K.S., Vollenweider P., Waeber G., Wallace C., Watanabe R.M., Waterworth D.M., Watkins N., Witteman J.C., Zeggini E., Zhai G., Zillikens M.C., Altshuler D., Caulfield M.J., Chanock S.J., Farooqi I.S., Ferrucci L., Guralnik J.M., Hattersley A.T., Hu F.B., Jarvelin M.R., Laakso M., Mooser V., Ong K.K., Ouwehand W.H., Salomaa V., Samani N.J., Spector T.D., Tuomi T., Tuomilehto J., Uda M., Uitterlinden A.G., Wareham N.J., Deloukas P., Frayling T.M., Groop L.C., Hayes R.B., Hunter D.J., Mohlke K.L., Peltonen L., Schlessinger D., Strachan D.P., Wichmann H.E., McCarthy M.I., Boehnke M., Barroso I., Abecasis G.R., Hirschhorn J.N. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 2009, 41:25-34.
17. Estrada K., Krawczak M., Schreiber S., van Duijn K., Stolk L., van Meurs J.B., Liu F., Penninx B.W., Smit J.H., Vogelzangs N., Hottenga J.J., Willemsen G., de Geus E.J., Lorentzon M., von Eller-Eberstein H., Lips P., Schoor N., Pop V., de Keijzer J., Hofman A., Aulchenko Y.S., Oostra B.A., Ohlsson C., Boomsma D.I., Uitterlinden A.G., van Duijn C.M., Rivadeneira F., Kayser M. A genome-wide association study of northwestern Europeans involves the C-type natriuretic peptide signaling pathway in the etiology of human height variation. Hum. Mol. Genet. 2009, 18:3516-3524.
18. Soranzo N., Rivadeneira F., Chinappen-Horsley U., Malkina I., Richards J.B., Hammond N., Stolk L., Nica A., Inouye M., Hofman A., Stephens J., Wheeler E., Arp P., Gwilliam R., Jhamai P.M., Potter S., Chaney A., Ghori M.J., Ravindrarajah R., Ermakov S., Estrada K., Pols H.A., Williams F.M., McArdle W.L., van Meurs J.B., Loos R.J., Dermitzakis E.T., Ahmadi K.R., Hart D.J., Ouwehand W.H., Wareham N.J., Barroso I., Sandhu M.S., Strachan D.P., Livshits G., Spector T.D., Uitterlinden A.G., Deloukas P. Meta-analysis of genome-wide scans for human adult stature identifies novel loci and associations with measures of skeletal frame size. PLoS Genet. 2009, 5:e1000445.
19. Weedon M.N., Frayling T.M. Reaching new heights: insights into the genetics of human stature. Trends Genet. 2008, 24:595-603.
20. Kim J.J., Lee H.I., Park T., Kim K., Lee J.E., Cho N.H., Shin C., Cho Y.S., Lee J.Y., Han B.G., Yoo H.W., Lee J.K. Identification of 15 loci influencing height in a Korean population. J. Hum. Genet. 2010, 55:27-31.
21. Okada Y., Kamatani Y., Takahashi A., Matsuda K., Hosono N., Ohmiya H., Daigo Y., Yamamoto K., Kubo M., Nakamura Y., Kamatani N. A genome-wide association study in 19633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height loci. Hum. Mol. Genet. 2010, 19:2303-2312.
22. Kiani C., Chen L., Wu Y.J., Yee A.J., Yang B.B. Structure and function of aggrecan. Cell Res. 2002, 12:19-32.
23. Sovio U., Bennett A.J., Millwood I.Y., Molitor J., O'Reilly P.F., Timpson N.J., Kaakinen M., Laitinen J., Haukka J., Pillas D., Tzoulaki I., Hoggart C., Coin L.J., Whittaker J., Pouta A., Hartikainen A.L., Freimer N.B., Widen E., Peltonen L., Elliott P., McCarthy M.I., Jarvelin M.R. Genetic determinants of height growth assessed longitudinally from infancy to adulthood in the northern Finland birth cohort 1966. PLoS Genet. 2009, 5:e1000409.
24. Bastepe M. Relative functions of Galphas and its extra-large variant XLalphas in the endocrine system. Horm. Metab. Res. 2012, 44:732-740.
25. Tobi E.W., Lumey L.H., Talens R.P., Kremer D., Putter H., Stein A.D., Slagboom P.E., Heijmans B.T. DNA Methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum. Mol. Genet. 2009, 18:4046-4053.
26. Abdollahi A. LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions. J. Cell. Physiol. 2007, 210:16-25.
27. Wang L., Balas B., Christ-Roberts C.Y., Kim R.Y., Ramos F.J., Kikani C.K., Li C., Deng C., Reyna S., Musi N., Dong L.Q., DeFronzo R.A., Liu F. Peripheral disruption of the Grb10 gene enhances insulin signaling and sensitivity in vivo. Mol. Cell. Biol. 2007, 27:6497-6505.
28. Watanabe H., Shionyu M., Kimura T., Kimata K. Splicing factor 3b subunit 4 binds BMPR-IA and inhibits osteochondral cell differentiation. J. Biol. Chem. 2007, 282:20728-20738.
29. Gipp J., Gu G., Crylen C., Kasper S., Bushman W. Hedgehog pathway activity in the LADY prostate tumor model. Mol. Cancer 2007, 6:19.
30. Howe J.R., Bair J.L., Sayed M.G., Anderson M.E., Mitros F.A., Petersen G.M., Velculescu V.E., Traverso G., Vogelstein B. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat. Genet. 2001, 28:184-187.
31. Douglas J., Cilliers D., Coleman K., Tatton-Brown K., Barker K., Bernhard B., Burn J., Huson S., Josifova D., Lacombe D., Malik M., Mansour S., Reid E., Cormier-Daire V., Cole T., Rahman N. Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth. Nat. Genet. 2007, 39:963-965.
32. Ngan E.S., Lang B.H., Liu T., Shum C.K., So M.T., Lau D.K., Leon T.Y., Cherny S.S., Tsai S.Y., Lo C.Y., Khoo U.S., Tam P.K., Garcia-Barcelo M.M. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma. J. Natl. Cancer Inst. 2009, 101:162-175.
33. Cirulli V., Yebra M. Netrins: beyond the brain. Nat. Rev. Mol. Cell Biol. 2007, 8:296-306.
34. Ko S.Y., Dass C.R., Nurgali K. Netrin-1 in the developing enteric nervous system and colorectal cancer. Trends Mol. Med. 2012, 18:544-554.
35. Whittom A.A., Xu H., Hebert M.D. Coilin levels and modifications influence artificial reporter splicing. Cell. Mol. Life Sci. 2008, 65:1256-1271.
36. Bogolyubov D., Stepanova I., Parfenov V. Universal nuclear domains of somatic and germ cells: some lessons from oocyte interchromatin granule cluster and Cajal body structure and molecular composition. Bioessays 2009, 31:400-409.
37. Cristofari G., Adolf E., Reichenbach P., Sikora K., Terns R.M., Terns M.P., Lingner J. Human telomerase RNA accumulation in Cajal bodies facilitates telomerase recruitment to telomeres and telomere elongation. Mol. Cell 2007, 27:882-889.
38. Venteicher A.S., Artandi S.E. TCAB1: driving telomerase to Cajal bodies. Cell Cycle 2009, 8:1329-1331.
39. Williams N.K., Lucet I.S., Klinken S.P., Ingley E., Rossjohn J. Crystal structures of the Lyn protein tyrosine kinase domain in its Apo- and inhibitor-bound state. J. Biol. Chem. 2009, 284:284-291.
40. Stratton M.R., Campbell P.J., Futreal P.A. The cancer genome. Nature 2009, 458:719-724.
41. Stephens P.J., McBride D.J., Lin M.L., Varela I., Pleasance E.D., Simpson J.T., Stebbings L.A., Leroy C., Edkins S., Mudie L.J., Greenman C.D., Jia M., Latimer C., Teague J.W., Lau K.W., Burton J., Quail M.A., Swerdlow H., Churcher C., Natrajan R., Sieuwerts A.M., Martens J.W., Silver D.P., Langerod A., Russnes H.E., Foekens J.A., Reis-Filho J.S., Van't Veer L., Richardson A.L., Borresen-Dale A.L., Campbell P.J., Futreal P.A., Stratton M.R. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 2009, 462:1005-1010.
42. Guerra E., Trerotola M., Dell' Arciprete R., Bonasera V., Palombo B., El-Sewedy T., Ciccimarra T., Crescenzi C., Lorenzini F., Rossi C., Vacca G., Lattanzio R., Piantelli M., Alberti S. A bi-cistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res. 2008, 68:8113-8121.
43. Romani A., Guerra M., Trerotola M., Alberti S. Detection and analysis of spliced chimeric mRNAs in sequence databanks. Nucleic Acids Res. 2003, 31:1-8.
44. Plebani R., Oliver G.R., Trerotola M., Guerra E., Cantanelli P., Apicella L., Emerson A., Albiero A., Harkin P.D., Kennedy R.D., Alberti S. Long-range transcriptome sequencing reveals cancer cell growth regulatory chimeric mRNAs. Neoplasia 2012, 14:1087-1096.
45. Guerra E., Trerotola M., Aloisi A.L., Tripaldi R., Vacca G., La Sorda R., Lattanzio R., Piantelli M., Alberti S. The Trop-2 signalling network in cancer growth. Oncogene 2012, (Epub ahead of print). 10.1038/onc.2012.151.
46. Trerotola M., Li J., Alberti S., Languino L.R. Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axis. J. Cell Physiol. Physiol. 2012, 227(11):3670-3677.
47. Biankin A.V., Waddell N., Kassahn K.S., Gingras M.C., Muthuswamy L.B., Johns A.L., Miller D.K., Wilson P.J., Patch A.M., Wu J., Chang D.K., Cowley M.J., Gardiner B.B., Song S., Harliwong I., Idrisoglu S., Nourse C., Nourbakhsh E., Manning S., Wani S., Gongora M., Pajic M., Scarlett C.J., Gill A.J., Pinho A.V., Rooman I., Anderson M., Holmes O., Leonard C., Taylor D., Wood S., Xu Q., Nones K., Fink J.L., Christ A., Bruxner T., Cloonan N., Kolle G., Newell F., Pinese M., Mead R.S., Humphris J.L., Kaplan W., Jones M.D., Colvin E.K., Nagrial A.M., Humphrey E.S., Chou A., Chin V.T., Chantrill L.A., Mawson A., Samra J.S., Kench J.G., Lovell J.A., Daly R.J., Merrett N.D., Toon C., Epari K., Nguyen N.Q., Barbour A., Zeps N., Kakkar N., Zhao F., Wu Y.Q., Wang M., Muzny D.M., Fisher W.E., Brunicardi F.C., Hodges S.E., Reid J.G., Drummond J., Chang K., Han Y., Lewis L.R., Dinh H., Buhay C.J., Beck T., Timms L., Sam M., Begley K., Brown A., Pai D., Panchal A., Buchner N., De Borja R., Denroche R.E., Yung C.K., Serra S., Onetto N., Mukhopadhyay D., Tsao M.S., Shaw P.A., Petersen G.M., Gallinger S., Hruban R.H., Maitra A., Iacobuzio-Donahue C.A., Schulick R.D., Wolfgang C.L., Morgan R.A., Lawlor R.T., Capelli P., Corbo V., Scardoni M., Tortora G., Tempero M.A., Mann K.M., Jenkins N.A., Perez-Mancera P.A., Adams D.J., Largaespada D.A., Wessels L.F., Rust A.G., Stein L.D., Tuveson D.A., Copeland N.G., Musgrove E.A., Scarpa A., Eshleman J.R., Hudson T.J., Sutherland R.L., Wheeler D.A., Pearson J.V., McPherson J.D., Gibbs R.A., Grimmond S.M. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 2012, 491:399-405.
48. Bredesen D.E., Mehlen P., Rabizadeh S. Receptors that mediate cellular dependence. Cell Death Differ. 2005, 12:1031-1043.
49. Young H.M., Anderson R.B., Anderson C.R. Guidance cues involved in the development of the peripheral autonomic nervous system. Auton. Neurosci. 2004, 112:1-14.
50. Rodrigues S., De Wever O., Bruyneel E., Rooney R.J., Gespach C. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis. Oncogene 2007, 26:5615-5625.
51. Madia F., Gattazzo C., Wei M., Fabrizio P., Burhans W.C., Weinberger M., Galbani A., Smith J.R., Nguyen C., Huey S., Comai L., Longo V.D. Longevity mutation in SCH9 prevents recombination errors and premature genomic instability in a Werner/Bloom model system. J. Cell Biol. 2008, 180:67-81.
52. Madia F., Wei M., Yuan V., Hu J., Gattazzo C., Pham P., Goodman M.F., Longo V.D. Oncogene homologue Sch9 promotes age-dependent mutations by a superoxide and Rev1/Polzeta-dependent mechanism. J. Cell Biol. 2009, 186:509-523.
53. Voordeckers K., Kimpe M., Haesendonckx S., Louwet W., Versele M., Thevelein J.M. Yeast 3-phosphoinositide-dependent protein kinase-1 (PDK1) orthologs Pkh1-3 differentially regulate phosphorylation of protein kinase A (PKA) and the protein kinase B (PKB)/S6K ortholog Sch9. J. Biol. Chem. 2011, 286:22017-22027.
54. Fabrizio P., Gattazzo C., Battistella L., Wei M., Cheng C., McGrew K., Longo V.D. Sir2 blocks extreme life-span extension. Cell 2005, 123:655-667.
55. Blander G., Guarente L. The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 2004, 73:417-435.
56. Huang H., Potter C.J., Tao W., Li D.M., Brogiolo W., Hafen E., Sun H., Xu T. PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development. Development 1999, 126:5365-5372.
57. Bohni R., Riesgo-Escovar J., Oldham S., Brogiolo W., Stocker H., Andruss B.F., Beckingham K., Hafen E. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell 1999, 97:865-875.
58. Maduzia L.L., Gumienny T.L., Zimmerman C.M., Wang H., Shetgiri P., Krishna S., Roberts A.F., Padgett R.W. Lon-1 regulates Caenorhabditis elegans body size downstream of the dbl-1 TGF beta signaling pathway. Dev. Biol. 2002, 246:418-428.
59. Jia K., Chen D., Riddle D.L. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 2004, 131:3897-3906.
60. Pinkston-Gosse J., Kenyon C. DAF-16/FOXO targets genes that regulate tumor growth in Caenorhabditis elegans. Nat. Genet. 2007, 39:1403-1409.
61. Amatruda J.F., Shepard J.L., Stern H.M., Zon L.I. Zebrafish as a cancer model system. Cancer Cell 2002, 1:229-231.
62. Patton E.E., Widlund H.R., Kutok J.L., Kopani K.R., Amatruda J.F., Murphey R.D., Berghmans S., Mayhall E.A., Traver D., Fletcher C.D., Aster J.C., Granter S.R., Look A.T., Lee C., Fisher D.E., Zon L.I. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr. Biol. 2005, 15:249-254.
63. Dovey M., White R.M., Zon L.I. Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish. Zebrafish 2009, 6:397-404.
64. Michailidou C., Jones M., Walker P., Kamarashev J., Kelly A., Hurlstone A.F. Dissecting the roles of Raf- and PI3K-signalling pathways in melanoma formation and progression in a zebrafish model. Dis. Model. Mech. 2009, 2:399-411.
65. Zhu S., Korzh V., Gong Z., Low B.C. RhoA prevents apoptosis during zebrafish embryogenesis through activation of Mek/Erk pathway. Oncogene 2008, 27:1580-1589.
66. Bartke A., Brown-Borg H. Life extension in the dwarf mouse. Curr. Top. Dev. Biol. 2004, 63:189-225.
67. Ikeno Y., Hubbard G.B., Lee S., Cortez L.A., Lew C.M., Webb C.R., Berryman D.E., List E.O., Kopchick J.J., Bartke A. Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64:522-529.
68. Vousden K.H., Lane D.P. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:275-283.
69. Matheu A., Maraver A., Klatt P., Flores I., Garcia-Cao I., Borras C., Flores J.M., Vina J., Blasco M.A., Serrano M. Delayed ageing through damage protection by the Arf/p53 pathway. Nature 2007, 448:375-379.
70. Rowell J.L., McCarthy D.O., Alvarez C.E. Dog models of naturally occurring cancer. Trends Mol. Med. 2011, 17:380-388.
71. Vail D.M., MacEwen E.G. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest. 2000, 18:781-792.
72. Rankin K.S., Starkey M., Lunec J., Gerrand C.H., Murphy S., Biswas S. Of dogs and men: comparative biology as a tool for the discovery of novel biomarkers and drug development targets in osteosarcoma. Pediatr. Blood Cancer 2011, 58:327-333.
73. Mueller F., Fuchs B., Kaser-Hotz B. Comparative biology of human and canine osteosarcoma. Anticancer Res. 2007, 27:155-164.
74. Sutter N.B., Ostrander E.A. Dog star rising: the canine genetic system. Nat. Rev. Genet. 2004, 5:900-910.
75. MacEwen E.G. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev. 1990, 9:125-136.
76. Leroy B.E., Northrup N. Prostate cancer in dogs: comparative and clinical aspects. Vet. J. 2009, 180:149-162.
77. Withrow S.J., Powers B.E., Straw R.C., Wilkins R.M. Comparative aspects of osteosarcoma. Dog versus man. Clin. Orthop. Relat. Res. 1991, 159-168.
78. Ru G., Terracini B., Glickman L.T. Host related risk factors for canine osteosarcoma. Vet. J. 1998, 156:31-39.
79. Tjalma R.A. Canine bone sarcoma: estimation of relative risk as a function of body size. J. Natl. Cancer Inst. 1966, 36:1137-1150.
80. Cooley D.M., Waters D.J. Skeletal neoplasms of small dogs: a retrospective study and literature review. J. Am. Anim. Hosp. Assoc. 1997, 33:11-23.
81. Johnson A.S., Couto C.G., Weghorst C.M. Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog. Carcinogenesis 1998, 19:213-217.
82. Mendoza S., Konishi T., Dernell W.S., Withrow S.J., Miller C.W. Status of the p53, Rb and MDM2 genes in canine osteosarcoma. Anticancer Res. 1998, 18:4449-4453.
83. van Leeuwen I.S., Cornelisse C.J., Misdorp W., Goedegebuure S.A., Kirpensteijn J., Rutteman G.R. P53 gene mutations in osteosarcomas in the dog. Cancer Lett. 1997, 111:173-178.
84. Flint A.F., U'Ren L., Legare M.E., Withrow S.J., Dernell W., Hanneman W.H. Overexpression of the erbB-2 proto-oncogene in canine osteosarcoma cell lines and tumors. Vet. Pathol. 2004, 41:291-296.
85. MacEwen E.G., Pastor J., Kutzke J., Tsan R., Kurzman I.D., Thamm D.H., Wilson M., Radinsky R. IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma. J. Cell. Biochem. 2004, 92:77-91.
86. Vousden K.H., Ryan K.M. p53 and metabolism. Nat. Rev. Cancer 2009, 9:691-700.
87. Kim J., Lee J.H., Iyer V.R. Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo. PLoS One 2008, 3:e1798.
88. de Caestecker M.P., Piek E., Roberts A.B. Role of Transforming Growth Factor-beta Signaling in Cancer. J. Natl. Cancer Inst. 2000, 92:1388-1402.
89. Gazzerro E., Canalis E. Bone morphogenetic proteins and their antagonists. Rev. Endocr. Metab. Disord. 2006, 7:51-65.
90. Cooper A.F., Yu K.P., Brueckner M., Brailey L.L., Johnson L., McGrath J.M., Bale A.E. Cardiac and CNS defects in a mouse with targeted disruption of suppressor of fused. Development 2005, 132:4407-4417.
91. Katoh Y., Katoh M. Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review). Int. J. Mol. Med. 2006, 18:1019-1023.
92. Varnat F., Duquet A., Malerba M., Zbinden M., Mas C., Gervaz P., Ruiz i Altaba A. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol. Med. 2009, 1:338-351.
93. Dupont S., Zacchigna L., Adorno M., Soligo S., Volpin D., Piccolo S., Cordenonsi M. Convergence of p53 and TGF-beta signaling networks. Cancer Lett. 2004, 213:129-138.
94. Yagi K., Furuhashi M., Aoki H., Goto D., Kuwano H., Sugamura K., Miyazono K., Kato M. c-Myc is a downstream target of the Smad pathway. J. Biol. Chem. 2001, 277:854-861.
95. Cordenonsi M., Dupont S., Maretto S., Insinga A., Imbriano C., Piccolo S. Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell 2003, 113:301-314.
96. Stecca B., Ruiz i Altaba A. A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J. 2009, 28:663-676.
97. Bailey J.M., Mohr A.M., Hollingsworth M.A. Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene 2009, 28:3513-3525.
98. Flora A., Klisch T.J., Schuster G., Zoghbi H.Y. Deletion of Atoh1 disrupts Sonic Hedgehog signaling in the developing cerebellum and prevents medulloblastoma. Science 2009, 326:1424-1427.
99. Kasperczyk H., Baumann B., Debatin K.M., Fulda S. Characterization of sonic hedgehog as a novel NF-kappaB target gene that promotes NF-kappaB-mediated apoptosis resistance and tumor growth in vivo. FASEB J. 2009, 23:21-33.
100. Himes S.R., Reeves R., Attema J., Nissen M., Li Y., Shannon M.F. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation. J. Immunol. 2000, 164:3157-3168.
101. Noro B., Licheri B., Sgarra R., Rustighi A., Tessari M.A., Chau K.Y., Ono S.J., Giancotti V., Manfioletti G. Molecular dissection of the architectural transcription factor HMGA2. Biochemistry 2003, 42:4569-4577.
102. Feng J.Q., Xing L., Zhang J.H., Zhao M., Horn D., Chan J., Boyce B.F., Harris S.E., Mundy G.R., Chen D. NF-kappaB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. J. Biol. Chem. 2003, 278:29130-29135.
103. Kirch H.C., Flaswinkel S., Rumpf H., Brockmann D., Esche H. Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max. Oncogene 1999, 18:2728-2738.
104. Grimsrud C.D., Romano P.R., D'Souza M., Puzas J.E., Schwarz E.M., Reynolds P.R., Roiser R.N., O'Keefe R.J. BMP signaling stimulates chondrocyte maturation and the expression of Indian hedgehog. J. Orthop. Res. 2001, 19:18-25.
105. Hirsinger E., Duprez D., Jouve C., Malapert P., Cooke J., Pourquie O. Noggin acts downstream of Wnt and Sonic Hedgehog to antagonize BMP4 in avian somite patterning. Development 1997, 124:4605-4614.
106. Li H., Liu J.P. Mechanisms of action of TGF-beta in cancer: evidence for Smad3 as a repressor of the hTERT gene. Ann. N. Y. Acad. Sci. 2007, 1114:56-68.
107. Kaji H., Naito J., Sowa H., Sugimoto T., Chihara K. Smad3 differently affects osteoblast differentiation depending upon its differentiation stage. Horm. Metab. Res. 2006, 38:740-745.
108. Guo X., Wang X.F. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res. 2009, 19:71-88.
109. Li C.G., Liang Q.Q., Zhou Q., Menga E., Cui X.J., Shu B., Zhou C.J., Shi Q., Wang Y.J. A continuous observation of the degenerative process in the intervertebral disc of Smad3 gene knock-out mice. Spine (Phila Pa 1976) 2009, 34:1363-1369.
110. Orian A., van Steensel B., Delrow J., Bussemaker H.J., Li L., Sawado T., Williams E., Loo L.W., Cowley S.M., Yost C., Pierce S., Edgar B.A., Parkhurst S.M., Eisenman R.N. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 2003, 17:1101-1114.
111. Kenneth N.S., White R.J. Regulation by c-Myc of ncRNA expression. Curr. Opin. Genet. Dev. 2009, 19:38-43.
112. Kohn K.W. Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Mol. Biol. Cell 1999, 10:2703-2734.
113. Guccione E., Martinato F., Finocchiaro G., Luzi L., Tizzoni L., Dall' Olio V., Zardo G., Nervi C., Bernard L., Amati B. Myc-binding-site recognition in the human genome is determined by chromatin context. Nat. Cell Biol. 2006, 8:764-770.
114. Cole M.D., Cowling V.H. Transcription-independent functions of MYC: regulation of translation and DNA replication. Nat. Rev. Mol. Cell Biol. 2008, 9:810-815.
115. Meyer N., Penn L.Z. Reflecting on 25years with MYC. Nat. Rev. Cancer 2008, 8:976-990.
116. Sebastian C., Zwaans B.M., Silberman D.M., Gymrek M., Goren A., Zhong L., Ram O., Truelove J., Guimaraes A.R., Toiber D., Cosentino C., Greenson J.K., MacDonald A.I., McGlynn L., Maxwell F., Edwards J., Giacosa S., Guccione E., Weissleder R., Bernstein B.E., Regev A., Shiels P.G., Lombard D.B., Mostoslavsky R. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 2013, 151:1185-1199.
117. Morrish F., Isern N., Sadilek M., Jeffrey M., Hockenbery D.M. c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene 2009, 28:2485-2491.
118. Dai M.S., Lu H. Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer. J. Cell. Biochem. 2008, 105:670-677.
119. Huberts D.H., van der Klei I.J. Moonlighting proteins: an intriguing mode of multitasking. Biochim. Biophys. Acta 2010, 1803:520-525.
120. Shor E., Warren C.L., Tietjen J., Hou Z., Muller U., Alborelli I., Gohard F.H., Yemm A.I., Borisov L., Broach J.R., Weinreich M., Nieduszynski C.A., Ansari A.Z., Fox C.A. The origin recognition complex interacts with a subset of metabolic genes tightly linked to origins of replication. PLoS Genet. 2009, 5:e1000755.
121. Rao G., Pedone C.A., Coffin C.M., Holland E.C., Fults D.W. c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice. Neoplasia 2003, 5:198-204.
122. Frederick J.P., Liberati N.T., Waddell D.S., Shi Y., Wang X.F. Transforming growth factor beta-mediated transcriptional repression of c-Myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol. Cell. Biol. 2004, 24:2546-2559.
123. Sachdeva M., Zhu S., Wu F., Wu H., Walia V., Kumar S., Elble R., Watabe K., Mo Y.Y. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3207-3212.
124. Lowe S.W., Sherr C.J. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 2003, 13:77-83.
125. Musgrove E.A., Sergio C.M., Loi S., Inman C.K., Anderson L.R., Alles M.C., Pinese M., Caldon C.E., Schutte J., Gardiner-Garden M., Ormandy C.J., McArthur G., Butt A.J., Sutherland R.L. Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer. PLoS One 2008, 3:e2987.
126. Rodrik V., Zheng Y., Harrow F., Chen Y., Foster D.A. Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc. Mol. Cell. Biol. 2005, 25:7917-7925.
127. Buchakjian M.R., Kornbluth S. The engine driving the ship: metabolic steering of cell proliferation and death. Nat. Rev. Mol. Cell Biol. 2010, 11:715-727.
128. TeKippe M., Harrison D.E., Chen J. Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice. Exp. Hematol. 2003, 31:521-527.
129. Cimoli G., Malacarne D., Ponassi R., Valenti M., Alberti S., Parodi S. Meta-analysis of the role of p53 status in isogenic systems tested for sensitivity to cytotoxic antineoplastic drugs. Biochim. Biophys. Acta 2004, 1705:103-120.
130. Biganzoli E., Coradini D., Ambrogi F., Garibaldi J.M., Lisboa P., Soria D., Green A.R., Pedriali M., Piantelli M., Querzoli P., Demicheli R., Boracchi P., Nenci I., Ellis I.O., Alberti S. p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features. Jpn. J. Clin. Oncol. 2011, 41:172-179.
131. Ambrogi F., Biganzoli E., Querzoli P., Ferretti S., Boracchi P., Alberti S., Marubini E., Nenci I. Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods. Clin. Cancer Res. 2006, 12:781-790.
132. Achanta G., Sasaki R., Feng L., Carew J.S., Lu W., Pelicano H., Keating M.J., Huang P. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J. 2005, 24:3482-3492.
133. Nasr A.F., Nutini M., Palombo B., Guerra E., Alberti S. Mutations ofTP53 induce loss of DNA methylation and amplification of the TROP1 gene. Oncogene 2003, 22:1668-1677.
134. Alberti S., Nutini M., Herzenberg L.A. DNA methylation prevents the amplification of TROP1, a tumor associated cell surface antigen gene. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:5833-5837.
135. Ronneberg J.A., Fleischer T., Solvang H.K., Nordgard S.H., Edvardsen H., Potapenko I., Nebdal D., Daviaud C., Gut I., Bukholm I., Naume B., Borresen-Dale A.L., Tost J., Kristensen V. Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer. Mol. Oncol. 2010, 5:61-76.
136. Fullwood M.J., Liu M.H., Pan Y.F., Liu J., Xu H., Mohamed Y.B., Orlov Y.L., Velkov S., Ho A., Mei P.H., Chew E.G., Huang P.Y., Welboren W.J., Han Y., Ooi H.S., Ariyaratne P.N., Vega V.B., Luo Y., Tan P.Y., Choy P.Y., Wansa K.D., Zhao B., Lim K.S., Leow S.C., Yow J.S., Joseph R., Li H., Desai K.V., Thomsen J.S., Lee Y.K., Karuturi R.K., Herve T., Bourque G., Stunnenberg H.G., Ruan X., Cacheux-Rataboul V., Sung W.K., Liu E.T., Wei C.L., Cheung E., Ruan Y. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009, 462:58-64.
137. Welboren W.J., Stunnenberg H.G., Sweep F.C., Span P.N. Identifying estrogen receptor target genes. Mol. Oncol. 2007, 1:138-143.
138. Juul A. The effects of oestrogens on linear bone growth. Hum. Reprod. Update 2001, 7:303-313.
139. Dahlgren A., Lundmark P., Axelsson T., Lind L., Syvanen A.C. Association of the estrogen receptor 1 (ESR1) gene with body height in adult males from two Swedish population cohorts. PLoS One 2008, 3:e1807.
140. Schuit S.C., van Meurs J.B., Bergink A.P., van der Klift M., Fang Y., Leusink G., Hofman A., van Leeuwen J.P., Uitterlinden A.G., Pols H.A. Height in pre- and postmenopausal women is influenced by estrogen receptor alpha gene polymorphisms. J. Clin. Endocrinol. Metab. 2004, 89:303-309.
141. Leung K.C., Doyle N., Ballesteros M., Sjogren K., Watts C.K., Low T.H., Leong G.M., Ross R.J., Ho K.K. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1016-1021.
142. Calado R.T., Yewdell W.T., Wilkerson K.L., Regal J.A., Kajigaya S., Stratakis C.A., Young N.S. Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood 2009, 114:2236-2243.
143. Hayashi S.I., Eguchi H., Tanimoto K., Yoshida T., Omoto Y., Inoue A., Yoshida N., Yamaguchi Y. The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application. Endocr. Relat. Cancer 2003, 10:193-202.
144. Ottaviano Y.L., Issa J.P., Parl F.F., Smith H.S., Baylin S.B., Davidson N.E. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 1994, 54:2552-2555.
145. Lau K.M., LaSpina M., Long J., Ho S.M. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res. 2000, 60:3175-3182.
146. Wei M., Xu J., Dignam J., Nanda R., Sveen L., Fackenthal J., Grushko T.A., Olopade O.I. Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers. Breast Cancer Res. Treat. 2008, 111:113-120.
147. Suga Y., Miyajima K., Oikawa T., Maeda J., Usuda J., Kajiwara N., Ohira T., Uchida O., Tsuboi M., Hirano T., Kato H., Ikeda N. Quantitative p16 and ESR1 methylation in the peripheral blood of patients with non-small cell lung cancer. Oncol. Rep. 2008, 20:1137-1142.
148. Mori T., Martinez S.R., O'Day S.J., Morton D.L., Umetani N., Kitago M., Tanemura A., Nguyen S.L., Tran A.N., Wang H.J., Hoon D.S. Estrogen receptor-alpha methylation predicts melanoma progression. Cancer Res. 2006, 66:6692-6698.
149. Shirley S.H., Rundhaug J.E., Tian J., Cullinan-Ammann N., Lambertz I., Conti C.J., Fuchs-Young R. Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells. Cancer Res. 2009, 69:3405-3414.
150. Koga K., Nakamura M., Nakashima H., Akiyoshi T., Kubo M., Sato N., Kuroki S., Nomura M., Tanaka M., Katano M. Novel link between estrogen receptor alpha and hedgehog pathway in breast cancer. Anticancer Res. 2008, 28:731-740.
151. Zhang M., Yan J.D., Zhang L., Wang Q., Lu S.J., Zhang J., Zhu T.H. Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen. Chin. Med. J. (Engl) 2005, 118:1629-1636.
152. Battle M.A., Konopka G., Parviz F., Gaggl A.L., Yang C., Sladek F.M., Duncan S.A. Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:8419-8424.
153. Wisely G., Miller A., Davis R., Thornquest A., Johnson R., Spitzer T., Sefler A., Shearer B., Moore J., Willson T., Williams S. Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure (Camb) 2002, 10:1225.
154. Hwang-Verslues W.W., Sladek F.M. HNF4alpha-role in drug metabolism and potential drug target?. Curr. Opin. Pharmacol. 2010, 10:698-705.
155. Sandovici I., Smith N.H., Nitert M.D., Ackers-Johnson M., Uribe-Lewis S., Ito Y., Jones R.H., Marquez V.E., Cairns W., Tadayyon M., O'Neill L.P., Murrell A., Ling C., Constancia M., Ozanne S.E. Maternal diet and aging alter the epigenetic control of a promoter-enhancer interaction at the Hnf4a gene in rat pancreatic islets. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:5449-5454.
156. Pearson E.R., Boj S.F., Steele A.M., Barrett T., Stals K., Shield J.P., Ellard S., Ferrer J., Hattersley A.T. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med. 2007, 4:e118.
157. Calabrese G., Crescenzi C., Morizio E., Palka G., Guerra E., Alberti S. Assignment of TACSTD1 (alias TROP1, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias TROP2, M1S1) to human chromosome 1p32 by in situ hybridization. Cytogenet. Cell Genet. 2001, 92:164-165.
158. Zanna P., Trerotola M., Vacca G., Bonasera V., Palombo B., Guerra E., Rossi C., Lattanzio R., Piantelli M., Alberti S. Trop-1 is a novel cell growth stimulatory molecule that marks early stages of tumor progression. Cancer 2007, 110:452-464.
159. Chellappa K., Jankova L., Schnabl J.M., Pan S., Brelivet Y., Fung C.L., Chan C., Dent O.F., Clarke S.J., Robertson G.R., Sladek F.M. Src tyrosine kinase phosphorylation of nuclear receptor HNF4alpha correlates with isoform-specific loss of HNF4alpha in human colon cancer. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:2302-2307.
160. Guevara-Aguirre J., Balasubramanian P., Guevara-Aguirre M., Wei M., Madia F., Cheng C.W., Hwang D., Martin-Montalvo A., Saavedra J., Ingles S., de Cabo R., Cohen P., Longo V.D. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 2011, 3:70ra13.
161. Trerotola M., Cantanelli P., Guerra E., Tripaldi R., Aloisi A.L., Bonasera V., Lattanzio R., de Lange R., Weidle U.H., Piantelli M., Alberti S. Up-regulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene 2013, 32:222-233.
162. Trerotola M., Rathore S., Goel H.L., Li J., Alberti S., Piantelli M., Adams D., Jiang Z., Languino L.R. CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells. Am. J. Transl. Res. 2010, 2:135-144.
163. Gururaj A.E., Peng S., Vadlamudi R.K., Kumar R. Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1). Mol. Endocrinol. 2007, 21:1847-1860.
164. Hirai Y., Utsugi K., Takeshima N., Kawamata Y., Furuta R., Kitagawa T., Kawaguchi T., Hasumi K., Noda T. Putative gene loci associated with carcinogenesis and metastasis of endocervical adenocarcinomas of uterus determined by conventional and array-based CGH. Am. J. Obstet. Gynecol. 2004, 191:1173-1182.
165. La Starza R., Crescenzi B., Pierini V., Romoli S., Gorello P., Brandimarte L., Matteucci C., Kropp M.G., Barba G., Martelli M.F., Mecucci C. A common 93-kb duplicated DNA sequence at 1q21.2 in acute lymphoblastic leukemia and Burkitt lymphoma. Cancer Genet. Cytogenet. 2007, 175:73-76.
166. Walz C., Metzgeroth G., Haferlach C., Schmitt-Graeff A., Fabarius A., Hagen V., Prummer O., Rauh S., Hehlmann R., Hochhaus A., Cross N.C., Reiter A. Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta gene. Haematologica 2007, 92:163-169.
167. Sun L.S., Li X.F., Li T.J. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors. J. Dent. Res. 2008, 87:575-579.
168. Germani A., Prabel A., Mourah S., Podgorniak M.P., Di Carlo A., Ehrlich R., Gisselbrecht S., Varin-Blank N., Calvo F., Bruzzoni-Giovanelli H. SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway. Oncogene 2003, 22:8845-8851.
169. Chinnadurai G. CtIP, a candidate tumor susceptibility gene is a team player with luminaries. Biochim. Biophys. Acta 2006, 1765:67-73.
170. De Bortoli M., Castellino R.C., Lu X.Y., Deyo J., Sturla L.M., Adesina A.M., Perlaky L., Pomeroy S.L., Lau C.C., Man T.K., Rao P.H., Kim J.Y. Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8. BMC Cancer 2006, 6:223.
171. Brummelkamp T.R., Kortlever R.M., Lingbeek M., Trettel F., MacDonald M.E., van Lohuizen M., Bernards R. TBX-3, the gene mutated in ulnar-mammary syndrome, is a negative regulator of p19ARF and inhibits senescence. J. Biol. Chem. 2002, 277:6567-6572.
172. Jacobs J.J., Keblusek P., Robanus-Maandag E., Kristel P., Lingbeek M., Nederlof P.M., van Welsem T., van de Vijver M.J., Koh E.Y., Daley G.Q., van Lohuizen M. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat. Genet. 2000, 26:291-299.
173. Abe A., Emi N., Tanimoto M., Terasaki H., Marunouchi T., Saito H. Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution. Blood 1997, 90:4271-4277.
174. Solimini N.L., Luo J., Elledge S.J. Non-oncogene addiction and the stress phenotype of cancer cells. Cell 2007, 130:986-988.
175. Luo J., Solimini N.L., Elledge S.J. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009, 136:823-837.
176. Mitelman F., Johansson B., Mertens F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer 2007, 7:233-245.
177. Esteller M. Epigenetics in cancer. N. Engl. J. Med. 2008, 358:1148-1159.
178. Jin B., Ernst J., Tiedemann R.L., Xu H., Sureshchandra S., Kellis M., Dalton S., Liu C., Choi J.H., Robertson K.D. Linking DNA methyltransferases to epigenetic marks and nucleosome structure genome-wide in human tumor cells. Cell Rep. 2012, 2:1411-1424.
179. McMurray H.R., Sampson E.R., Compitello G., Kinsey C., Newman L., Smith B., Chen S.R., Klebanov L., Salzman P., Yakovlev A., Land H. Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature 2008, 453:1112-1116.
180. Dai C., Whitesell L., Rogers A.B., Lindquist S. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 2007, 130:1005-1018.
181. Kauffman S., Peterson C., Samuelsson B., Troein C. Random Boolean network models and the yeast transcriptional network. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:14796-14799.
182. Greer E.L., Maures T.J., Ucar D., Hauswirth A.G., Mancini E., Lim J.P., Benayoun B.A., Shi Y., Brunet A. Transgenerational epigenetic inheritance of longevity in Caenorhabditis elegans. Nature 2011, 479:365-371.
183. Alberti S., Herzenberg L.A. DNA methylation prevents transfection of genes for specific surface antigens. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:8391-8394.
184. Kurotaki N., Imaizumi K., Harada N., Masuno M., Kondoh T., Nagai T., Ohashi H., Naritomi K., Tsukahara M., Makita Y., Sugimoto T., Sonoda T., Hasegawa T., Chinen Y., Tomita Ha H.A., Kinoshita A., Mizuguchi T., Yoshiura Ki K., Ohta T., Kishino T., Fukushima Y., Niikawa N., Matsumoto N. Haploinsufficiency of NSD1 causes Sotos syndrome. Nat. Genet. 2002, 30:365-366.
185. Berdasco M., Ropero S., Setien F., Fraga M.F., Lapunzina P., Losson R., Alaminos M., Cheung N.K., Rahman N., Esteller M. Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:21830-21835.
186. Ingolia N.T., Murray A.W. Positive-feedback loops as a flexible biological module. Curr. Biol. 2007, 17:668-677.
187. Simmons Kovacs L.A., Mayhew M.B., Orlando D.A., Jin Y., Li Q., Huang C., Reed S.I., Mukherjee S., Haase S.B. Cyclin-dependent kinases are regulators and effectors of oscillations driven by a transcription factor network. Mol. Cell 2012, 45:669-679.
188. Dequeant M.L., Glynn E., Gaudenz K., Wahl M., Chen J., Mushegian A., Pourquie O. A complex oscillating network of signaling genes underlies the mouse segmentation clock. Science 2006, 314:1595-1598.
189. Lopez-Aviles S., Kapuy O., Novak B., Uhlmann F. Irreversibility of mitotic exit is the consequence of systems-level feedback. Nature 2009, 459:592-595.
190. Ninfa A.J., Mayo A.E. Hysteresis vs. graded responses: the connections make all the difference. Sci. STKE 2004, 2004:pe20.
191. Domazet-Loso T., Tautz D. Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa. BMC Biol. 2010, 8:66.
192. Alberti S. The origin of the genetic code and protein synthesis. J. Mol. Evol. 1997, 45:352-358.
193. Orr H.A. Fitness and its role in evolutionary genetics. Nat. Rev. Genet. 2009, 10:531-539.
194. Verginelli F., Aru F., Battista P., Mariani-Costantini R. Nutrigenetics in the light of human evolution. J. Nutrigenet. Nutrigenomics 2009, 2:91-102.
195. Constancia M., Kelsey G., Reik W. Resourceful imprinting. Nature 2004, 432:53-57.
196. Rossi D.J., Jamieson C.H., Weissman I.L. Stems cells and the pathways to aging and cancer. Cell 2008, 132:681-696.